Cardene and Accupril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cardene (nicardipine hydrochloride) and Accupril (quinapril hydrochloride). Common drug interactions include pain among females and hepatic failure among males.

The phase IV clinical study analyzes what interactions people have when they take Cardene and Accupril. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cardene?

Cardene has active ingredients of nicardipine hydrochloride. eHealthMe is studying from 729 Cardene users. Check the latest studies of Cardene.

What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,404 Accupril users. Check the latest studies of Accupril.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

11 people who take Cardene and Accupril together, and have interactions are studied.

Cardene and Accupril drug interactions.

What are the common drug interactions of Cardene and Accupril, by gender? *:

female:

  1. Pain

male:

  1. Hepatic failure (liver failure)
  2. Hepatitis (inflammation of the liver)
  3. Rheumatoid factor positive
  4. Flatulence (flatus expelled through the anus)
  5. Inappropriate antidiuretic hormone secretion
  6. Ketonuria (ketones in urine)
  7. Leukocytosis (increased white blood cells)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Cough
  10. Fall

What are the common drug interactions of Cardene and Accupril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Hepatic failure (liver failure)
  2. Hepatitis (inflammation of the liver)
  3. Rheumatoid factor positive
  4. Flatulence (flatus expelled through the anus)
  5. Inappropriate antidiuretic hormone secretion
  6. Ketonuria (ketones in urine)
  7. Leukocytosis (increased white blood cells)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Cough
  10. Fall

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 2 people, 18.18%
  2. Cardiac Disorder: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Cardene and Accupril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cardene and Accupril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cardene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Accupril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cardene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Accupril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nicardipine hydrochloride and quinapril hydrochloride (the active ingredients of Cardene and Accupril, respectively), and Cardene and Accupril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: